Streetbeat News

Revenues

INGXF

Innergex has strategically reduced its dividend and refinanced its hydro assets to boost liquidity for new projects, without diluting shareholders. Despite weak Q3 results, the company has made progress on key projects and highlighted the hidden value of its hydro assets.

Portfolio Pulse from

November 11, 2024 | 6:15 am

ZTS

Zoetis has been given a 'Buy' rating with a target price of $210 per share, driven by strong performance of its osteoarthritis drugs, LIBRELA and SOLENSIA, which saw 97% operational revenue growth. Zoetis projects significant revenue and net income growth for FY24.

Portfolio Pulse from

November 11, 2024 | 4:30 am

BAH

Booz Allen Hamilton reported strong Q2 financial results with 18% revenue growth and 27.3% adjusted operating income growth, driven by federal defense and civil markets. The company expects significant growth in its cybersecurity business.

Portfolio Pulse from

November 11, 2024 | 4:30 am

GMRE

Global Medical REIT's Q3-2024 results indicate flat rental revenue and AFFO. The bankruptcy of Steward Health Care resulted in a new lease with CHRISTUS Health. Concerns are raised about the sustainability of the high dividend yield, with a $10.00 price ceiling suggested.

Portfolio Pulse from

November 11, 2024 | 3:00 am

CFRHF

Richemont, the owner of Cartier, reported results that missed expectations due to weaker demand in China and a decline in luxury watch sales.

Portfolio Pulse from

November 11, 2024 | 2:30 am

IDXX

IDEXX Laboratories faces weak demand in the U.S. clinical market, leading to a 'Sell' rating and a price target of $400. Q3 results showed a decline in clinical visits and missed expectations, prompting lowered revenue guidance for FY24. Macroeconomic challenges and high-interest rates are expected to impact growth.

Portfolio Pulse from

November 11, 2024 | 1:00 am

TJX

TJX Companies is expected to report strong Q3 FY2025 earnings, potentially beating conservative guidance due to strong US consumer spending and favorable freight costs. The company's international growth strategy is highlighted by its investment in Brands for Less and store expansion.

Portfolio Pulse from

November 10, 2024 | 5:30 pm

STRL

Sterling Infrastructure (STRL) is benefiting from strong trends in North America's infrastructure construction market, particularly in data centers and advanced manufacturing. The company's E-Infrastructure Solutions segment has become its largest revenue stream, enhancing operating margins and supporting growth initiatives.

Portfolio Pulse from

November 10, 2024 | 4:15 pm

EVT

EVT offers a diversified portfolio with a focus on equities and fixed-income, favoring the financial sector. The fund's 7.85% distribution yield is primarily funded by capital gains, and potential Fed rate cuts could ease borrowing costs, increasing NII coverage.

Portfolio Pulse from

November 10, 2024 | 3:45 pm

CBDD

CBD of Denver reported an increase in Q3 2024 revenue to $763,450, up from $677,893 in Q3 2023. The company also provided updates on its spinoff and the German market following the Cannabis Act's implementation.

Portfolio Pulse from

November 10, 2024 | 3:45 pm